Free Trial

Xeris Biopharma (XERS) SEC Filings & 10K Form

Xeris Biopharma logo
$4.38 +0.22 (+5.29%)
Closing price 04:00 PM Eastern
Extended Trading
$4.46 +0.09 (+1.94%)
As of 06:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Xeris Biopharma SEC Filings

DateFilerForm TypeView
04/03/2025
3:20 PM
McCulloch Kevin (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2025
3:44 PM
Brady James Aloysius (Reporting)
Xeris Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/21/2025
4:31 PM
Hecht Beth (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
4:26 PM
Hecht Beth (Reporting)
Xeris Biopharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2025
3:07 PM
Xeris Biopharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/06/2025
6:21 AM
Xeris Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/24/2025
7:09 AM
Xeris Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/03/2025
6:39 PM
JOHNSON KENNETH ERLAND (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
6:39 PM
Pieper Steven (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
6:39 PM
Hecht Beth (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
6:40 PM
Shannon John Patrick Jr (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
6:40 PM
McCulloch Kevin (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
6:17 AM
Xeris Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
3:40 PM
Hecht Beth (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:42 PM
Pieper Steven (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:42 PM
JOHNSON KENNETH ERLAND (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:42 PM
McCulloch Kevin (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:43 PM
Shannon John Patrick Jr (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
4:00 PM
Pieper Steven (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
6:13 AM
Xeris Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
3:15 PM
Schmid John P. (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
5:28 PM
Schmid John P. (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
3:27 PM
Xeris Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/08/2024
6:15 AM
Xeris Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2024
4:22 PM
McCulloch Kevin (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2024
4:22 PM
Shannon John Patrick Jr (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
6:14 AM
Xeris Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
3:15 PM
Xeris Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
3:18 PM
HALKUFF DAWN (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:18 PM
Kong Garheng (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:18 PM
PERSKY MARLA (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:18 PM
JOHNSON JOHN (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:19 PM
BORMANN-KENNEDY BARBARA-JEAN ANNE (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:19 PM
SHERMAN JEFFREY W (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:19 PM
Fairley Ricki Louise (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:19 PM
Schmid John P. (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
3:19 PM
Xeris Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
6:14 AM
Xeris Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2024
3:32 PM
Xeris Biopharma (Filer)
Form ARS
04/23/2024
3:24 PM
Xeris Biopharma (Filer)
Form DEF 14A
04/23/2024
3:26 PM
Xeris Biopharma (Filer)
Form DEFA14A
Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad)

Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.

Click here to see how you could take a stake in Elon’s private company…
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:XERS) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners